Bullock Wealth Management’s Arcadia Biosciences RKDA Stock Holding History

Bullock Wealth Management’s Portfolio RKDA Stock Details RKDA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$749	Buy	+1,000	New	+$1.04K	﹤0.01%	583

Other funds holding RKDA

HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return

StoneX Group New York $2.48B AUM 33.54% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return

Bullock Wealth Management's RKDA Position: Q2 2026 in Review

Bullock Wealth Management opened a new position in Arcadia Biosciences (RKDA) in Q2 2026: 1,000 shares worth $749. The stake represents ﹤0.01% of the portfolio and ranks #583 among its holdings.

18 funds tracked by Wall St. Rank hold RKDA as of Q2 2026.

Bullock Wealth Management held 1,000 shares of Arcadia Biosciences worth $749 as of Q2 2026.
Arcadia Biosciences was a new Bullock Wealth Management position in Q2 2026.
Arcadia Biosciences made up ﹤0.01% of Bullock Wealth Management's portfolio in Q2 2026, its #583 holding.
18 funds tracked by Wall St. Rank held Arcadia Biosciences as of Q2 2026.

Based on Bullock Wealth Management's 13F filing for Q2 2026, filed 19 Aug 2026.